Northwest Investment Counselors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11
Closed -$3K 611
2021
Q4
$3K Buy
+11
New +$2.83K ﹤0.01% 467
2021
Q2
Sell
-11
Closed -$3K 179
2021
Q1
$3K Buy
+11
New +$2.97K ﹤0.01% 454
2020
Q4
Sell
-11
Closed -$3K 173
2020
Q3
$3K Buy
+11
New +$3.07K ﹤0.01% 429
2019
Q4
Sell
-11
Closed -$3K 182
2019
Q3
$3K Buy
+11
New +$2.56K ﹤0.01% 471
2017
Q4
Sell
-10
Closed -$3K 155
2017
Q3
$3K Hold
10
﹤0.01% 331
2017
Q2
$3K Buy
+10
New +$2.64K ﹤0.01% 293

Other funds holding BIIB

Northwest Investment Counselors's BIIB Position: Q1 2022 in Review

Northwest Investment Counselors sold out of Biogen (BIIB) in Q1 2022, closing a stake of 11 shares — an estimated $3K sold.

Northwest Investment Counselors first reported a position in BIIB in Q2 2017 and held it in 6 quarters. The position peaked at $3K in Q4 2021. 953 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Northwest Investment Counselors reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Northwest Investment Counselors sold 11 Biogen shares in Q1 2022, an estimated $3K.
  • Northwest Investment Counselors first reported a position in Biogen in Q2 2017 and held it in 6 quarters.
  • Northwest Investment Counselors's Biogen position peaked at $3K in Q4 2021.
  • 953 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Northwest Investment Counselors's 13F filing for Q1 2022, filed 18 Apr 2022.